After the success of the technical feasibility, the Swiss company SAV-IOL is now seeking investors for cataract surgery intraocular lens of intelligent active projects

Disclaimer: This article is a blogger original article, follow the CC 4.0 BY-SA copyright agreement, reproduced, please attach the original source link and this statement.
This link: https://blog.csdn.net/sinat_41698914/article/details/100562290

Neuchatel, Switzerland - (BUSINESS WIRE) - SAV-IOL (Swiss Advanced Vision) is promoting the development of R-TASC project, which is the first with real-time autofocus electronic intraocular lens (IOL), aims to complete restore vision after cataract surgery. R-TASC coming in the next 5 - to expand the boundaries of the field of ophthalmology seven years. SAV-IOL has verified the technical feasibility of the project, now is looking to raise $ 20 million to market this breakthrough instrument.

Although the IOL market is vast, but since the advent of its few substantial innovations. In addition, there has been subject to some of the IOL depends optical defects, for example, limited adjustment range of vision, light vision missing or unnecessary interference. To break the barriers, SAV-IOL is by virtue of intelligent active crystal viewing the situation from a different angle. R-TASC electronically controlled, to control the curvature as the optical mechanism through a feedback loop to adjust the ratio of the crystal. Max Boysset SAV-IOL chief executive officer, said: "At present, all IOLs on the market have a certain degree of defects .R-TASC deal with common problems associated IOL through a new method."

Standard IOLs can not completely replace the natural lens of the optical properties of view, R-TASC adaptability depends on the optical design is the answer to this problem. In addition to fully restore vision system adjustment, R-TASC and allows the patient to the surgeon after cataract surgery through a control app regulated with crystals. R-TASC wireless platform can also be upgraded in the future, integrated augmented reality and other interactive features, open the possibility of a wave of new ophthalmic industry had never seen before.

SAV-IOL will be held in September 2019 at the 37th ESCRS Congress in Paris (Hall 7 Stand I123) and in November 2019 held in Dusseldorf MEDICA exhibition (Swiss start-ups angle) to show the latest on R -TASC prototype.

About SAV-IOL : SAV-IOL is a development, manufacturing and marketing EDOF IOL Swiss company. SAV-IOL product line includes three products: Harmonis (customizable EDOF IOL), Eden (boutique EDOF IOL) and Lucidis (parity EDOF IOL). SAV-IOL has ISO 13485: 2016 certification (MD 615363), the crystal CE mark (CE 615365).

Guess you like

Origin blog.csdn.net/sinat_41698914/article/details/100562290